Related Experiment Video
Updated: Oct 28, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Reducing body myopathy associated with the LIM2 p.(His123Arg) FHL1 variant
Leila Darki1, Arash Jalali-Sohi1, Samuel Guzman2
1Neuromuscular Division, Department of Neurology of the University of Southern California Keck School of Medicine, Los Angeles, CA, United States.
Abstract:
Reducing body myopathy (RBM) is a rare muscle disorder, with marked presence of characteristic intracytoplasmic aggregates in affected muscle fibers. RBM is associated with FHL1 gene mutations. Clinical presentations of RBM have ranged from early fatal to adult onset progressive muscle weakness. We present herein the clinical, electrodiagnostic, and muscle biopsy findings of a 17-year-old female with progressive muscle weakness and contracture. Muscle biopsy showed atrophic fibers that contained menadione nitroblue tetrazolium (NBT) positive reducing bodies. Genetic testing revealed a variant of uncertain significance in the FHL1 gene at a position known to be pathogenic when substituted by other amino acids (p.His123Arg). This variant was later reclassified as pathogenic.
Insights
Reducing body myopathy (RBM) is a rare genetic muscle disorder. This case highlights a pathogenic FHL1 gene variant causing progressive muscle weakness and contractures in a young female.
Area of Science:
- Neurology
- Genetics
- Muscle Biology
Background:
- Reducing body myopathy (RBM) is a rare neuromuscular disorder characterized by specific protein aggregates within muscle fibers.
- Mutations in the FHL1 gene are a known cause of RBM, presenting with variable clinical severity.
- The spectrum of RBM ranges from severe infantile forms to adult-onset progressive muscle weakness.
Observation:
- A 17-year-old female presented with progressive muscle weakness and contractures.
- Muscle biopsy revealed atrophic muscle fibers containing characteristic menadione nitroblue tetrazolium (NBT)-positive reducing bodies.
- Electrophysiological studies supported a myopathic process.
Findings:
- Genetic analysis identified a variant in the FHL1 gene (p.His123Arg).
- Initially classified as a variant of uncertain significance, this FHL1 variant was subsequently reclassified as pathogenic.
- This pathogenic variant is located at a known mutation hotspot for RBM.
Implications:
- This case expands the understanding of FHL1-associated RBM phenotypes.
- Accurate genetic classification is crucial for diagnosing and managing rare myopathies.
- Further research into FHL1 variants may elucidate genotype-phenotype correlations in RBM.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Satellite Stem Cells and Muscular Dystrophy
Lysosomal Hydrolases
Lethal Alleles
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...

